This report contains market size and forecasts of 3rd Generation EGFR in global, including the following market information:
Global 3rd Generation EGFR Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 3rd Generation EGFR Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five 3rd Generation EGFR companies in 2021 (%)
The global 3rd Generation EGFR market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibody Class Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 3rd Generation EGFR include Shanghai Allist Pharmaceuticals, Betta Pharmaceuticals and Nanjing Sanhome Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 3rd Generation EGFR manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 3rd Generation EGFR Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global 3rd Generation EGFR Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibody Class
Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Global 3rd Generation EGFR Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global 3rd Generation EGFR Market Segment Percentages, by Application, 2021 (%)
Lung Cancer
Liver Cancer
Stomach Cancer
Other
Global 3rd Generation EGFR Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global 3rd Generation EGFR Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 3rd Generation EGFR revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 3rd Generation EGFR revenues share in global market, 2021 (%)
Key companies 3rd Generation EGFR sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies 3rd Generation EGFR sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Allist Pharmaceuticals
Betta Pharmaceuticals
Nanjing Sanhome Pharmaceutical